HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Yin Selected Research

Ro 25-1553

1/2013Vasodilatory effect of the stable vasoactive intestinal peptide analog RO 25-1553 in murine and rat lungs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Yin Research Topics

Disease

134Neoplasms (Cancer)
04/2024 - 03/2006
34Inflammation (Inflammations)
11/2023 - 10/2007
25Hypoxia (Hypoxemia)
11/2023 - 03/2006
22Infections
02/2024 - 03/2008
21Esophageal Neoplasms (Esophageal Cancer)
11/2023 - 01/2013
19Type 2 Diabetes Mellitus (MODY)
03/2024 - 01/2008
19Body Weight (Weight, Body)
11/2023 - 07/2008
17Breast Neoplasms (Breast Cancer)
01/2023 - 11/2016
16Hepatocellular Carcinoma (Hepatoma)
01/2024 - 12/2011
15Obesity
03/2024 - 10/2007
15Lung Neoplasms (Lung Cancer)
02/2024 - 05/2008
15Neoplasm Metastasis (Metastasis)
11/2023 - 03/2008
14Sepsis (Septicemia)
01/2023 - 01/2011
14Insulin Resistance
10/2022 - 01/2008
12Alzheimer Disease (Alzheimer's Disease)
01/2024 - 11/2005
12Adenocarcinoma
06/2023 - 04/2010
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 01/2014
11Acute Lung Injury
08/2023 - 01/2009
10Edema (Dropsy)
03/2023 - 04/2008
9Hyperglycemia
03/2024 - 06/2008
9Carcinoma (Carcinomatosis)
02/2024 - 04/2006
9Neuroinflammatory Diseases
01/2023 - 10/2016
8Non-alcoholic Fatty Liver Disease
05/2024 - 03/2015
8Epilepsy (Aura)
01/2023 - 01/2017
7Pain (Aches)
02/2024 - 06/2008
7Melanoma (Melanoma, Malignant)
11/2023 - 01/2021
7Heart Failure
11/2023 - 03/2009
7Esophageal Squamous Cell Carcinoma
02/2023 - 01/2015
7Hypertension (High Blood Pressure)
05/2022 - 04/2012
6Fibrosis (Cirrhosis)
04/2024 - 01/2013
6Prostatic Neoplasms (Prostate Cancer)
12/2023 - 01/2016
6Brain Neoplasms (Brain Tumor)
11/2023 - 03/2013
6Seizures (Absence Seizure)
01/2023 - 11/2011
6Lung Injury
12/2022 - 11/2013
6Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 05/2017
5Cognitive Dysfunction
12/2023 - 02/2016
5Nasopharyngeal Carcinoma
12/2023 - 04/2017
5Lymphoma (Lymphomas)
10/2023 - 01/2018
5Colitis
01/2023 - 06/2011
5Disease Progression
12/2022 - 10/2018
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2022 - 01/2018
5Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2022 - 10/2018
5Hemorrhage
01/2022 - 06/2011
5Thrombosis (Thrombus)
01/2022 - 01/2017
5Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2021 - 01/2014
5Myocardial Infarction
08/2020 - 09/2002
5Bone Resorption
06/2016 - 05/2003
4Neurodegenerative Diseases (Neurodegenerative Disease)
12/2023 - 01/2009
4Vascular Diseases (Vascular Disease)
11/2023 - 01/2013
4Weight Loss (Weight Reduction)
11/2023 - 07/2008
4Cholangiocarcinoma
11/2023 - 12/2021

Drug/Important Bio-Agent (IBA)

59Proteins (Proteins, Gene)FDA Link
02/2024 - 12/2003
27Biomarkers (Surrogate Marker)IBA
12/2023 - 02/2015
22MicroRNAs (MicroRNA)IBA
01/2023 - 01/2013
20Glucose (Dextrose)FDA LinkGeneric
04/2024 - 03/2006
17CytokinesIBA
08/2023 - 10/2007
13RNA (Ribonucleic Acid)IBA
04/2024 - 12/2003
13Insulin (Novolin)FDA Link
10/2022 - 05/2008
11LipidsIBA
04/2024 - 02/2010
11Messenger RNA (mRNA)IBA
12/2023 - 01/2010
11Peptides (Polypeptides)IBA
01/2023 - 06/2008
11Transcription Factors (Transcription Factor)IBA
11/2021 - 10/2007
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2023 - 10/2007
8UbiquitinIBA
02/2024 - 01/2012
8EnzymesIBA
01/2023 - 03/2006
7DNA (Deoxyribonucleic Acid)IBA
01/2023 - 12/2003
7Blood Glucose (Blood Sugar)IBA
10/2022 - 01/2016
7InterleukinsIBA
01/2022 - 10/2013
6fibroblast growth factor 21IBA
05/2024 - 01/2016
6Antiviral Agents (Antivirals)IBA
02/2024 - 03/2008
6Interleukin-6 (Interleukin 6)IBA
08/2023 - 10/2016
6Long Noncoding RNAIBA
01/2023 - 06/2016
6Cisplatin (Platino)FDA LinkGeneric
01/2023 - 01/2014
6AntibodiesIBA
01/2023 - 02/2008
6Inosine Triphosphate (ITP)IBA
01/2022 - 10/2018
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 05/2011
6Triglycerides (Triacylglycerol)IBA
12/2021 - 06/2010
5Phosphotransferases (Kinase)IBA
01/2024 - 01/2012
5Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2023 - 02/2022
5Indicators and Reagents (Reagents)IBA
12/2023 - 12/2003
5AntigensIBA
11/2023 - 01/2012
5Immune Checkpoint InhibitorsIBA
01/2023 - 01/2022
5Caspase 3 (Caspase-3)IBA
01/2022 - 02/2018
5AcidsIBA
01/2019 - 06/2007
5Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2015 - 11/2005
42- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
02/2024 - 01/2016
4SolutionsIBA
01/2024 - 07/2014
4Sirtuin 1IBA
11/2023 - 06/2010
4InflammasomesIBA
09/2023 - 01/2018
4Therapeutic UsesIBA
08/2023 - 01/2016

Therapy/Procedure

67Therapeutics
05/2024 - 05/2007
24Drug Therapy (Chemotherapy)
11/2023 - 03/2006
15Immunotherapy
04/2024 - 12/2016
11Radiotherapy
03/2023 - 03/2006
9Neoadjuvant Therapy
11/2023 - 06/2017
8Chemoradiotherapy
12/2022 - 07/2016
6Transplantation
03/2024 - 12/2021
5Ligation
01/2019 - 02/2015
4Gastric Bypass (Roux-en-Y Gastric Bypass)
03/2024 - 11/2012
4Carbohydrate-Restricted Diet (Low Carbohydrate Diet)
11/2023 - 01/2021